Rockland Childrens Psychiatric Center Sullivan Comm Servs and Day Trt Prog

Located in Macon, GA, Rockland Childrens Psychiatric Center Sullivan Comm Servs and Day Trt Prog operates within the GA regulatory framework as a licensed addiction-treatment provider. The facility's programming is outpatient (Outpatient, MAT), not residential. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.

Care levels at Rockland Childrens Psychiatric Center Sullivan Comm Servs and Day Trt Prog

Level-of-care documentation: Rockland Childrens Psychiatric Center Sullivan Comm Servs and Day Trt Prog is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Under MHPAEA 2024 medical-necessity criteria disclosure, plan-specific criteria for each of these levels must be available to patients upon request. Mismatch between documented clinical need and offered level of care is a common source of authorization denial.

Insurance and payment

Rockland Childrens Psychiatric Center Sullivan Comm Servs and Day Trt Prog operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Before you call

Pre-admission due-diligence for Rockland Childrens Psychiatric Center Sullivan Comm Servs and Day Trt Prog: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via GA behavioral-health regulator inspection records. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.